MARKET

BEAT

BEAT

BioTelemetry
NASDAQ

Real-time Quotes | Nasdaq Last Sale

43.40
-1.27
-2.84%
Opening 10:43 08/14 EDT
OPEN
44.28
PREV CLOSE
44.67
HIGH
44.49
LOW
43.39
VOLUME
41.63K
TURNOVER
--
52 WEEK HIGH
55.85
52 WEEK LOW
27.35
MARKET CAP
1.48B
P/E (TTM)
82.15
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BEAT stock price target is 62.20 with a high estimate of 80.00 and a low estimate of 52.00.

EPS

BEAT News

More
BioTelemetry Inc (BEAT) Q2 2020 Earnings Call Transcript
Ladies and gentlemen, good afternoon, and thank you for joining us for the BioTelemetry Second Quarter 2020 Earnings Conference Call. Such statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performa
Motley Fool · 07/31 07:01
BioTelemetry (BEAT) Beats Q2 Earnings and Revenue Estimates
BioTelemetry (BEAT) delivered earnings and revenue surprises of 191.67% and 15.34%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 07/30 23:50
BioTelemetry inks sales agent agreement with Boston Scientific
Boston Scientific (BSX -3.1%) has announced a sales agent agreement with BioTelemetry (BEAT +6.1%), for BSX's LUX-Dx Insertable Cardiac Monitor (ICM) Syste
seekingalpha · 07/30 20:15
BioTelemetry Q2 EPS $0.35 Beats $0.16 Estimate, Sales $89.41M Miss $89.52M Estimate
BioTelemetry (NASDAQ:BEAT) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.16 by 118.75 percent. This is a 33.96 percent decrease over earnings of $0.53 per share from the
Benzinga · 07/30 20:07
BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
Posts Strong Results and Ramps Up Business Development ActivityMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of l
GlobeNewswire · 07/30 20:05
BioTelemetry Earlier Reported Sales Agent Deal With Boston Scientific For LUX-Dx Insertable Cardiac Monitor System, No Terms Disclosed
Benzinga · 07/30 12:57
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)
Benzinga · 07/30 12:09
BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation
Company expands portfolio of solutions with groundbreaking insertable cardiac monitor systemMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health inform
GlobeNewswire · 07/30 11:00

Industry

Healthcare Facilities & Services
+0.45%
Healthcare Providers & Services
+0.26%

Hot Stocks

Symbol
Price
%Change

About BEAT

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates in three segments: Healthcare, Technology and Research. The Healthcare segment, operating as CardioNet, LLC and Heartcare Corporation of America, Inc., is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Research segment, operating as Cardiocore, LLC and VirtualScopics, Inc., is engaged in laboratory services that provide cardiac monitoring, imaging services, scientific consulting and data management services for drug, medical treatment and device trials. The Technology segment, operating as Braemar Manufacturing, LLC, Universal Medical, Inc. and BioTelemetry Belgium BVBA. and BioTelemetry Technology ApS, focuses on the manufacturing, engineering and development of noninvasive cardiac monitors for healthcare companies.
More

Webull offers kinds of BioTelemetry Inc stock information, including NASDAQ:BEAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BEAT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BEAT stock methods without spending real money on the virtual paper trading platform.